C J Tack, P Smits, P N DeMacker, A F Stalenhoef. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Chromans/therapeutic useDiabetes Mellitus/bloodDiabetes Mellitus/drug therapyDiabetes Mellitus, Type 2/bloodDiabetes Mellitus, Type 2/drug therapyDouble-Blind MethodHumansHypoglycemic Agents/therapeutic useInsulin ResistanceLipoprotein(a)/bloodObesityThiazoles/therapeutic useThiazolidinedionesTroglitazone
Substances: See more » ChromansHypoglycemic AgentsLipoprotein(a)ThiazolesThiazolidinedionesTroglitazone
Year: 1999 PMID: 10526754 DOI: 10.2337/diacare.22.10.1752
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112